STK11 and lung carcinoma: In addition, LKB1 loss also was observed concurrently with KRAS oncogenic mutation promoting pancreatic tumorigenesis by suppression of P21-dependent growth arrest and with BRAF V600E inducing lung adenomas progression to lung carcinomas by overcoming senescence [17, 18].